MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Location

Founded

1989-12-19

Risk Signals

4960 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Live alerts from global media, monitored by Business Radar

Texas :  UK : Legal News & Analysis

2025-04-11 (law360.com)

Texas : UK : Legal News & Analysis

Legal news and analysis on Texas litigation, policy, deals. Covers lawsuits, regulation, enforcement, legislation, mergers, acquisitions, judicial appointments.

Read more
The DDEC urges to approve legislation on the Global Minimum Tax in Puerto Rico

2024-09-04 (elnuevodia.com)

The DDEC urges to approve legislation on the Global Minimum Tax in Puerto Rico

Manuel Cidre, secretary of the agency, reacted to the call made to the government by the CEO of Medtronic about the importance of implementing the global rate of 15%

Read more
Medtronic urges Puerto Rico to legislate on the Global Minimum Tax

2024-09-04 (elnuevodia.com)

Medtronic urges Puerto Rico to legislate on the Global Minimum Tax

The chief executive officer of one of the world’s leading medical device manufacturers, Geoff Martha, said that if action is not taken, the island’s competitiveness and industrial growth could be affected

Read more
Project Jameson and the “used-for test”: How Medtronic overturned a €45.9m tax bill

2024-04-12 (thecurrency.news)

Project Jameson and the “used-for test”: How Medtronic overturned a €45.9m tax bill

On Thursday, Mr Justice David Nolan delivered the High Court’s judgment in one of several tax battles opposing the multinational medical supplier Medtronic and the Revenue Commissioners. In this case, the judge re-examined a 2022 Tax Appeals Commission( TAC) determination made after poring over“ 32

Read more
Carmat : Universal registration document | MarketScreener

2020-03-13 (marketscreener.com)

Carmat : Universal registration document | MarketScreener

Avril 2001 - E. Lancet. 2001 Aug 11;358:439-44. ... | March 13, 2020

Read more
Medtronic, now based in Ireland, still reaps U.S. benefits

2016-09-09 (startribune.com)

Medtronic, now based in Ireland, still reaps U.S. benefits

Since its "inversion," the company has been awarded more than $40 million in federal contracts and its executives still work at its Fridley campus.

Read more
News Briefs: Updates From Around The Industry

2015-12-02 (informa.com)

News Briefs: Updates From Around The Industry

Device industry news on Dec. 2 includes an IDE approval to study a super-small neurostimulator to treat face pain; distribution agreements in diabetes and blood processing; a product approval; and new legislation focused on telemedicine.

Read more
New U.S. tax rules may lead Medtronic to redo inversion deal

2014-09-29 (reuters.com)

New U.S. tax rules may lead Medtronic to redo inversion deal

U.S. medical device maker Medtronic Inc is likely to try to renegotiate the structure and terms of its $42.9 billion deal to buy Ireland's Covidien Plc in response to new U.S. tax rules, according to people familiar with the situation.

Read more
What could Congress do about Medtronic’s move overseas? | MinnPost

2014-07-23 (minnpost.com)

What could Congress do about Medtronic’s move overseas? | MinnPost

WASHINGTON — Deals like Medtronic's planned move to Ireland are becoming more common, and lawmakers in both parties are looking to discourage them.

Read more
Medtronic Wants Cardiac Monitors to Avoid California Sales Tax

(bloomberglaw.com)

Medtronic Wants Cardiac Monitors to Avoid California Sales Tax

Medtronic USA Inc. told a California appeals court Friday that implanted devices used to detect irregular heartbeats are exempt from sales tax because they qualify as medicine under state law.

Read more
Medtronic-Covidien Merger Receives Regulatory Approval From China, South Korea

(meddeviceonline.com)

Medtronic-Covidien Merger Receives Regulatory Approval From China, South Korea

Medtronic Inc. recently announced that regulatory authorities in China and South Korea have given clearances for the company to proceed with its proposed $43 billion merger with Covidien, just several days after U.S. and Canadian antitrust bodies gave their approval.

Read more

Never miss a headline about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages